Financials
Value Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 357 K268 K211 K220 K 1.06 M Research & development ———— — Operating income 64.53 M72.88 M85.55 M82.99 M 305.95 M Non-Operating Income, Total 1.25 M9.18 M6.66 M9.46 M 26.55 M Interest expense, net of interest capitalized 447 K392 K72 K4 000 915 K Non-Operating Income, excl. Interest Expenses 799 K8.79 M6.59 M9.46 M 25.64 M Unusual income/expense ———— — Pretax income 22.33 M29.73 M33.16 M34.23 M 119.45 M Equity in earnings ———— — Taxes 4.71 M6.12 M6.71 M7.05 M 24.6 M Non-controlling/minority interest -5 000952 K1.19 M1.71 M 3.85 M After tax other income/expense ———— — Net income before discontinued operations 17.62 M22.66 M25.25 M25.47 M 91.01 M Discontinued operations ———— — Net income 17.62 M22.66 M25.25 M25.47 M 91.01 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 17.03 M22.66 M25.25 M25.47 M 90.42 M Basic earnings per share (Basic EPS) 0.40.470.570.53 1.97 Diluted earnings per share (Diluted EPS) 0.390.450.540.51 1.89 Average basic shares outstanding 42.08 M48.07 M44.66 M48.07 M — Diluted shares outstanding 43.58 M49.97 M46.23 M49.77 M — EBITDA 50.85 M58.97 M70.7 M67.6 M 248.12 M EBIT 64.69 M73.54 M86.1 M83.57 M 307.9 M Cost of revenue 36.57 M41.64 M43.27 M45.71 M 167.18 M Other cost of goods sold ———— — Depreciation & amortization (cash flow) -13.85 M-14.56 M-15.4 M-15.97 M -59.78 M